Bausch Health Companies BHC Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Bausch + Lomb | $5.1B+6.5% | $4.79B+15.6% | $4.15B+10.0% | $3.77B+0.1% | |
| Diversified | $937M-1.4% | $950M+0.7% | $943M-3.6% | $978M-12.8% | |
| International | $1.13B+1.9% | $1.11B+3.7% | $1.07B+8.4% | $988M-15.3% | |
| Salix | $2.58B+10.5% | $2.33B+3.7% | $2.25B+7.7% | $2.09B+0.8% | |
| Solta Medical | $518M+17.7% | $440M+26.8% | $347M+15.7% | $300M-2.6% | |
| Revenue by Product | |||||
| Other revenues | $110M+2.8% | $107M+13.8% | $94M-5.1% | $99M-6.6% | |
| Price Appreciation Credit | $18M0.0% | $18M+63.6% | $11M+10.0% | $10M— | |
| Product sales | $10.16B+6.7% | $9.52B+9.9% | $8.66B+8.0% | $8.03B-3.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch Health Companies break its business down?
- Bausch Health Companies (BHC) reports revenue by business across 5 parts — Bausch + Lomb, Diversified, International, Salix and Solta Medical. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch Health Companies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch Health Companies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.